ANTI-SENTRIN-2 C??? ??, ??, ??

?? ??

Covalent modification of target lysines by SUMO (small ubiquitin-like modifier) modulates processes such as protein localization, transcription, nuclear transport, mitosis, DNA replication and repair, signal transduction, and viral reproduction. SUMO does not seem to be involved in protein degradation and may in fact function as an antagonist of ubiquitin in the degradation process. The SUMO family consists of SUMO1 and closely related homologs SUMO2, SUMO3, and SUMO4. Sumoylation has been shown to regulate a wide range of proteins, including MDM2, PIAS, PML, RanGAP1, RanBP2, p53, p73, HIPK2, TEL, c-Jun, Fas, Daxx, TNFRI, Topo-I, Topo-II, PARK2, WRN, Sp100, IkB-alpha, Androgen receptor (AR), GLUT1/4, CaMK, DNMT3B, TDG, HIF1A, CHD3, EXOSC9, RAD51, and viral targets such as CMV-IE1/2, EBV-BZLF1, and HPV/BPV-E1.

ANTI-SENTRIN-2 ?? ?? ? ???

???

?? ??

ANTI-SENTRIN-2 ?? ??

???	??	???	??	?? ?	??
Nanjing Anyan Biological Technology Co., Ltd.	025-52151215 13915956535 13915956535	570945402@qq.com	China	9733	58
Atlas antibodies	46-854595850	order@atlasantibodies.com	China	6586	58
Merck KGaA	21-20338288	ordercn@merckgroup.com	China	6394	58
Wanlei Life Sciences (Shenyang) Co Ltd	400-6020407	sales@wanleibio.com	China	1216	58
Beijing Biosynthesis Biotechnology Co Ltd	400-9019800	sales@bioss.com.cn	China	6102	58